Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RDEA806 in HIV-1 positive, antiretroviral naïve subjects
NCT00617526Phase 2Completed
- Sponsor
- Ardea Biosciences, Inc.
- Start
- Jan 2008
- Primary completion
- Jun 2008
- Countries
- 2
01
Overview
A Phase 2 trial of lersivirine in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Ardea Biosciences, Inc.. Started Jan 2008; status: completed.
02
Drugs
lersivirine
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT00617526.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00617526.